Gabapentin Tablet
Product Images NDC 71335-1200

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Equation (Gabapentin Equation)

A mathematical formula for estimated creatinine clearance (CLCr) based on age, weight, serum creatinine, and adjustments for female patients. This formula appears as text in the image and relates to pharmacokinetic calculations.*

FDA Label Image

Gabapentin Fig1

A line graph depicting mean pain score over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks including a 4-week dose titration and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend, whereas placebo remains relatively constant.*

FDA Label Image

Gabapentin Fig2

A line graph displaying mean pain scores over a 7-week period with a 3-week dose titration phase followed by a 4-week fixed dose phase. It compares placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups, showing pain score trends across baseline and weeks 1 to 7.*

FDA Label Image

Gabapentin Fig3

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) dosages in two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance levels are noted, with GBP bars higher than placebo in both studies.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

A scatter plot showing percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin. Data points are labeled for three studies (a, b, c) across doses of 600, 900, 1200, and 1800 mg. The legend identifies each study with distinct square markers.*

FDA Label Image

Gabapentin-structure (Gabapentin Structure)

Chemical structure diagram of the active ingredient Gabapentin, showing the cyclohexane ring with amino and carboxymethyl side chains attached.*

FDA Label Image

Label Image (Lbl713351200)

Gabapentin 600 mg tablet label from Bryant Ranch Prepack. The label states it is a tablet form, with a white capsule G6 noted. It includes storage instructions at 20°-25°C (68°-77°F), a warning about possible dizziness, and advises to keep the medication out of reach of children. The label references comparison to Neurontin 600 mg tablets by Alkem Laboratories. The package size is #30 tablets and has an NDC number 71335-1201.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.